Guo Y et al., 2014-05: Randomised double-blind placebo-controlled trial of oral alpha-lipoic acid 600 mg three times daily for 24 weeks in patients receiving cisplatin or oxaliplatin: no significant difference in neuropathy scores, pain or function, and only 70 of 243 patients completed.
No statistically significant differences were found between the ALA and the placebo groups for FACT/GOG-Ntx scores, BPI scores, and patients' functional outcomes.
Abstract, Results and Conclusion
Guo Y et al., 2014-05: Randomised double-blind placebo-controlled trial of oral alpha-lipoic acid 600 mg three times daily for 24 weeks in patients receiving cisplatin or oxaliplatin: no significant difference in neuropathy scores, pain or function, and only 70 of 243 patients completed. Study type: randomized trial.
